1. Laboratory
  2. Sample management
  3. Powder Systems Limited (PSL)

Liquid filter drier LabMSR™
for solidslaboratoryfor the pharmaceutical industry

Liquid filter drier - LabMSR™ - Powder Systems Limited (PSL) - for solids / laboratory / for the pharmaceutical industry
Liquid filter drier - LabMSR™ - Powder Systems Limited (PSL) - for solids / laboratory / for the pharmaceutical industry
Liquid filter drier - LabMSR™ - Powder Systems Limited (PSL) - for solids / laboratory / for the pharmaceutical industry - image - 2
Add to favorites
Compare this product
 

Characteristics

Fluid
for liquids, for solids
Applications
laboratory, for the pharmaceutical industry
Other characteristics
vacuum, compact, pressure, high-efficiency, with agitation

Description

The LabMSR™ system is a GLP piece of equipment that has been developed to enable global drug manufacturers to generally replicate, at R&D scale, some of the process benefits of PSL’s full scale production MicroSphere Refiners (MSR™). Due to their characteristics and properties, polymeric microspheres have traditionally been known to be difficult to process for manufacturers – especially as the batch size gradually increases as part of the microsphere product development. The unique features of our LabMSR™ were developed following a Quality-by-Design (QbD) approach, taking into account the microspheres characteristics and process behaviour. An All-In-One Solution The purpose of the LabMSR™ is to provide R&D staff with an innovative tool enabling them to complete reliable product scale-up activities and refine their process parameters while being in a laboratory environment. The LabMSR™ will allow its end-users to reproduce the following processes, in particular: Microspheres Classification/Filtration/De-watering) Microsphere Washing Microspheres Drying, including Freeze-Drying Microsphere Discharge/Recovery Putting Your Scale-Up On Auto-Pilot Developing complex drug formulations such as microsphere delivery systems has traditionally been challenging for most drug manufacturers, big or small. Ensuring that the chosen process technology used at R&D or pilot stage can be fully scalable to larger production batches is crucial. Finding out too late that a microsphere process is not scalable can have devastating impact and cost millions of dollars to drug manufacturers. Microspheres are extremely valuable medicines to develop and produce.
*Prices are pre-tax. They exclude delivery charges and customs duties and do not include additional charges for installation or activation options. Prices are indicative only and may vary by country, with changes to the cost of raw materials and exchange rates.